Meri S, Pangburn M K
Department of Biochemistry, University of Texas Health Center, Tyler 75710.
Eur J Immunol. 1990 Dec;20(12):2555-61. doi: 10.1002/eji.1830201205.
In this work we studied the role of the classical pathway complement component C4b in the activation of the alternative pathway. It was found that nascent C3b attaches with high efficiency to C4b and that C3b in C4bC3b complexes is protected from inactivation by factors H and I. Activation of C3 by factors B and D in the presence of Mg2+ ions and excess C4b led to 35% incorporation of nascent C3b into C4bC3b complexes in the fluid phase. In comparison, when human IgG was tested as an acceptor under similar conditions, only 12% of generated C3b was incorporated into IgGC3b complexes. The half-life time of dissociation of C3b from purified C4bC3b complexes was approximately 2.3 h at 37 degrees C. C4b in these complexes protected C3b from inactivation as effectively as any known alternative pathway activator. Thus, C3b bound to C4b was tenfold more stable than free C3b or C3b bound to a nonactivating surface. In comparison, the protection provided by attachment to human IgG was only 67% of that of C4b. The results provide an explanation for observations of alternative pathway recruitment following classical pathway activation and for the stability of the classical pathway C5 convertase on surfaces which do not provide protection for C3b from factors H and I.
在本研究中,我们探讨了经典途径补体成分C4b在替代途径激活中的作用。研究发现,新生的C3b能高效地附着于C4b,且C4bC3b复合物中的C3b受到因子H和I的保护而不被灭活。在存在镁离子和过量C4b的情况下,因子B和D对C3的激活导致液相中35%的新生C3b掺入C4bC3b复合物。相比之下,在类似条件下将人IgG作为受体进行测试时,只有12%生成的C3b掺入IgGC3b复合物。在37℃时,C3b从纯化的C4bC3b复合物解离的半衰期约为2.3小时。这些复合物中的C4b保护C3b不被灭活的效果与任何已知的替代途径激活剂一样有效。因此,与C4b结合的C3b比游离的C3b或与非激活表面结合的C3b稳定10倍。相比之下,与人类IgG结合所提供的保护仅为C4b的67%。这些结果为经典途径激活后替代途径募集的观察结果以及经典途径C5转化酶在不能为C3b提供免受因子H和I保护的表面上的稳定性提供了解释。